Ken Griffin Scholar Rock Holding Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 7,600 shares of SRRK stock, worth $225,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,600
Previous 5,500
38.18%
Holding current value
$225,188
Previous $97,000
35.05%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SRRK
# of Institutions
173Shares Held
75.3MCall Options Held
151KPut Options Held
40.1K-
Artal Group S.A. Luxembourg, N411.3MShares$334 Million5.94% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.19MShares$243 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$201 Million29.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$168 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.45MShares$162 Million2.96% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.53B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...